Patents by Inventor Robert Lipper

Robert Lipper has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLODEXTRIN COMPLEXES OF SPECIALIZED PRORESOLVING MEDIATORS
    Publication number: 20260151505
    Abstract: The present invention provides complexes of a specialized pro-resolving mediator (SPM), or a salt, ester, or amide thereof, and a cyclodextrin (CD), wherein the SPM is a hydroxylated, polyunsaturated fatty acid derived from arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, or docosapentaenoic acid, 20 or 22 carbon atoms in length, with 4, 5 or 6 conjugated double bonds arranged in diene, triene, or tetraene systems or combinations thereof, and related compositions and methods.
    Type: Application
    Filed: January 26, 2026
    Publication date: June 4, 2026
    Applicant: THETIS PHARMACEUTICALS LLC
    Inventors: Gary Mathias, Frank C. Sciavolino, Robert Lipper
  • Cyclodextrin complexes of specialized proresolving mediators
    Patent number: 12564644
    Abstract: The present invention provides complexes of a specialized pro-resolving mediator (SPM), or a salt, ester, or amide thereof, and a cyclodextrin (CD), wherein the SPM is a hydroxylated, polyunsaturated fatty acid derived from arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, or docosapentaenoic acid, 20 or 22 carbon atoms in length, with 4, 5 or 6 conjugated double bonds arranged in diene, triene, or tetraene systems or combinations thereof; and related compositions and methods.
    Type: Grant
    Filed: March 1, 2023
    Date of Patent: March 3, 2026
    Assignee: Thetis Pharmaceuticals LLC
    Inventors: Gary Mathias, Frank C. Sciavolino, Robert Lipper
  • CYCLODEXTRIN COMPLEXES OF SPECIALIZED PRORESOLVING MEDIATORS
    Publication number: 20240408229
    Abstract: The present invention provides complexes of a specialized pro-resolving mediator (SPM), or a salt, ester, or amide thereof, and a cyclodextrin (CD), wherein the SPM is a hydroxylated, polyunsaturated fatty acid derived from arachidonic acid, eicosapentaenoic acid, docosahexaenoic acid, or docosapentaenoic acid, 20 or 22 carbon atoms in length, with 4, 5 or 6 conjugated double bonds arranged in diene, triene, or tetraene systems or combinations thereof; and related compositions and methods.
    Type: Application
    Filed: March 1, 2023
    Publication date: December 12, 2024
    Applicant: THETIS PHARMACEUTICALS LLC
    Inventors: Gary Mathias, Frank C. Sciavolino, Robert Lipper
  • Unitary pharmaceutical dosage form
    Publication number: 20070099902
    Abstract: In accordance with this invention a novel pharmaceutical product containing efavirenz, emtricitabine and tenofovir DF are provided as a multicomponent unitary oral dosage form, component 1 comprising tenofovir DF (and, optionally, emtricitabine) and component 2 comprising efavirenz, wherein components 1 and 2 are in a stabilizing configuration. In preferred embodiments component 1 is made by dry granulation.
    Type: Application
    Filed: June 13, 2006
    Publication date: May 3, 2007
    Inventors: Terrence Dahl, Munir Hussain, Robert Lipper, Robert Jerzewski, Mark Menning, Reza Oliyai, Taiyin Yang